Skip to content
Resources > Reports

The Ultimate Guide for Conducting Efficient and Comprehensive Due Diligence

Fluctuating interest rates and tightened credit have contributed to slowed M&A deal activity throughout 2023. Lingering macroeconomic uncertainty is requiring investors to be more critical than ever in their analyses in order to make informed decisions.

Over the past year, activity on the AlphaSense platform has increased by >50% for documents referencing ‘due diligence.’ As the data indicates—conducting the right due diligence is critical to deal success.

In this whitepaper, we examine the latest trends and best practices to help you navigate the shifting M&A landscape. Download the guide to uncover:

  • The current state of the market and economic factors that are influencing M&A deal activity
  • The right types of questions to ask a prospective seller that company documents and correspondence may not overtly address
  • An essential due diligence checklist covering potential areas of concern and vital documents needed to get the full picture

Explore more

Enterprise Software: Assessing AI Adoption Trends

Generative AI is moving from isolated pilots to full-scale deployments, with adoption accelerating in areas like software development and IT service management.
Title slide: Enterprise Software: Assessing AI Adoption Trends, by Michelle Brophy and Sean Carmichael, featuring a computer illustration and AI logo.

From Promise to Performance: How AI Will Evolve in 2026

2025 was the year generative AI grew up, shifting from isolated experiments to integrated systems. What also emerged was a clearer picture of how AI will continue to mature in 2026.
Title slide: From Promise to Performance: How AI Will Evolve in 2026 by Sarah Hoffman, Director of AI Thought Leadership, with abstract tech graphics.

Most-Favored-Nation Policy: Implications for European Drug Launches

The U.S. shift toward most-favored-nation (MFN) drug pricing is forcing pharmaceutical firms to rethink their pricing models and launch strategies in Europe.
U.S. Most-Favored-Nation Drug Pricing Policy: What Does It Mean for Europe? by Sara Mallatt and Sean Carmichael, with a stylized map of Europe.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.